• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Medical marijuana laws not linked to an increase teen marijuana use

byMelissa McCoyandStefan Trela
December 2, 2016
in Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. In states that passed a medical marijuana law at any time before 2014, there was a higher prevalence of marijuana use among adolescents within the previous 30 days than in states that had not passed medical marijuana laws.

2. In states that passed medical marijuana laws, there was not a significant difference in the risk of marijuana use in adolescents before passing medical marijuana laws compared to after passing the laws.

Evidence Rating Level: 3 (Average)

Study Rundown: The relationship between laws permitting medical marijuana use and marijuana use in adolescents is frequently debated. This study used national data to examine the relationship between adolescent use of marijuana and state medical marijuana laws. Data was collected for 24 years by administering a self-administered questionnaire on marijuana use to more than one million 8th, 10th, and 12th-grade students in nearly 400 schools across the United States. This study sought to assess if marijuana use was higher overall in states that had passed a medical marijuana law before 2014, and if the risk of marijuana use changed after the passage of medical marijuana laws.

The results showed that in states that had passed a medical marijuana law at any time until 2014, the prevalence of marijuana use in adolescents was higher than in states that had not passed any medical marijuana laws. However, in states that passed medical marijuana laws, there was not a significant increase in the risk of marijuana use among adolescents after passing the laws compared to before the laws were passed. This study was strengthened by its large sample size and the comprehensive analysis across a long time-span, however, variations in individual state laws were not examined, and some states had only recently passed medical marijuana laws before this study was conducted.

Click to read the study in The Lancet Psychiatry

RELATED REPORTS

The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage

The Scan by 2 Minute Medicine®: A Misconception about Miscarriage, Scandal and ADHD, 10000 Steps per Day and Marijuana During Pregnancy!

Medical cannabis provides little improvement to sleep in chronic pain patients

Relevant Reading: Effects of State Medical Marijuana Laws on Adolescent Marijuana Use

In-Depth [cross-sectional study]: This study was based on data collected in annually repeated cross-sectional surveys. The Monitoring the Future study instrument is a self-administered questionnaire conducted annually since 1991 by 8th, 10th, and 12th-grade students across the US (modal ages 13-14, 15-16, and 17-18 years, respectively). The primary outcome of the study was any marijuana use in the past 30 days, and the secondary outcome was whether or not the risk of marijuana use in adolescents changed after the passage of medical marijuana laws. Co-variables for individual, school, and state-level characteristics were controlled for in the study.

1,098,270 adolescents in 48 states were surveyed between 1991 and 2014. The results showed that in states that had passed a medical marijuana law any time up to 2014, there was a higher prevalence of marijuana use among adolescents within the previous 30 days than in states that had not passed medical marijuana laws (adjusted prevalence 15.87% vs. 13.27%; adjusted odds ratio [OR] 1.27, 95% CI 1.07-1.51; p=0.0057). However, in states that passed medical marijuana laws, there was not a significant difference in the risk of marijuana use in adolescents before passing medical marijuana laws compared to after passing the laws (adjusted prevalence 16.25% vs. 15.45%; adjusted OR 0.92, 95% CI 0.82-1.04; p=0.185).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: marijuana
Previous Post

Prognostic nomograms predict survival after chemoembolization of hepatocellular carcinoma

Next Post

Readmission to the same hospital after major surgery may reduce mortality

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage

May 14, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: A Misconception about Miscarriage, Scandal and ADHD, 10000 Steps per Day and Marijuana During Pregnancy!

October 4, 2022
Parental cannabis use increasing, cigarette use decreasing
Chronic Disease

Medical cannabis provides little improvement to sleep in chronic pain patients

July 6, 2022
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Wellness

Wellness Check: Sleep

July 6, 2022
Next Post
Age not associated with differences in radiosurgical arteriovenous malformation outcomes

Readmission to the same hospital after major surgery may reduce mortality

Engineered stem cells mitigate liver damage caused by radiation [PreClinical]

Reducing oxygen stress during stem cell collection improves transplantation efficacy [PreClinical]

Significant reduction in prostate screening rates after revised guidelines

Significant reduction in prostate screening rates after revised guidelines

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Video mental health care may have clinical advantages versus phone or in-person visits
  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.